Wolfram Kreß

7.8k total citations · 1 hit paper
113 papers, 4.0k citations indexed

About

Wolfram Kreß is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Wolfram Kreß has authored 113 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 38 papers in Cellular and Molecular Neuroscience and 26 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Wolfram Kreß's work include Muscle Physiology and Disorders (38 papers), Genetic Neurodegenerative Diseases (37 papers) and Cardiomyopathy and Myosin Studies (24 papers). Wolfram Kreß is often cited by papers focused on Muscle Physiology and Disorders (38 papers), Genetic Neurodegenerative Diseases (37 papers) and Cardiomyopathy and Myosin Studies (24 papers). Wolfram Kreß collaborates with scholars based in Germany, France and United States. Wolfram Kreß's co-authors include K. Ricker, Christina L. Liquori, Laura P.W. Ranum, Susan L. Naylor, Melinda L. Moseley, John Day, Benedikt Schoser, Clemens R. Müller, Jocelyn Laporte and Jean‐Louis Mandel and has published in prestigious journals such as Science, Molecular and Cellular Biology and Neurology.

In The Last Decade

Wolfram Kreß

111 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9

2001 918 citations Christina L. Liquori, K. Ricker et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wolfram Kreß Germany	33	2.9k	1.5k	637	630	533	113	4.0k
Morten Dunø Denmark	35	2.6k 0.9×	745 0.5×	481 0.8×	346 0.5×	650 1.2×	184	3.8k
Duygu Selcen United States	35	2.3k 0.8×	765 0.5×	979 1.5×	1.2k 1.8×	256 0.5×	87	3.8k
Dennis Dooijes Netherlands	38	3.2k 1.1×	598 0.4×	2.1k 3.3×	689 1.1×	619 1.2×	110	5.7k
Bjarne Udd Finland	39	3.8k 1.3×	1.2k 0.9×	2.1k 3.2×	989 1.6×	334 0.6×	158	5.2k
Lucía Morandi Italy	43	3.7k 1.2×	754 0.5×	786 1.2×	490 0.8×	359 0.7×	143	5.2k
Mary G. Sweeney United Kingdom	34	2.8k 1.0×	1.0k 0.7×	154 0.2×	702 1.1×	290 0.5×	71	4.0k
Andrew H. Crosby United Kingdom	36	3.9k 1.3×	1.7k 1.1×	1.0k 1.6×	569 0.9×	862 1.6×	125	7.1k
Beril Talim Türkiye	31	3.0k 1.0×	580 0.4×	492 0.8×	175 0.3×	405 0.8×	138	4.0k
Angela Huebner Germany	33	1.7k 0.6×	324 0.2×	380 0.6×	453 0.7×	476 0.9×	133	3.4k
Claudio Bruno Italy	37	3.3k 1.1×	483 0.3×	482 0.8×	231 0.4×	426 0.8×	146	4.6k

Countries citing papers authored by Wolfram Kreß

Since Specialization

Citations

This map shows the geographic impact of Wolfram Kreß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfram Kreß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfram Kreß more than expected).

Fields of papers citing papers by Wolfram Kreß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfram Kreß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfram Kreß. The network helps show where Wolfram Kreß may publish in the future.

Co-authorship network of co-authors of Wolfram Kreß

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfram Kreß. A scholar is included among the top collaborators of Wolfram Kreß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfram Kreß. Wolfram Kreß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nanda, Indrajit, et al.. (2022). Detection of pericentric inversion with breakpoint in DMD by whole genome sequencing. Molecular Genetics & Genomic Medicine. 10(10). e2028–e2028. 12 indexed citations

Rosenbohm, Angela, Steffen Hirsch, Alexander E. Volk, et al.. (2018). The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy. Journal of Neurology. 265(5). 1026–1036. 26 indexed citations

Petersen, Jens A., Thierry Küntzer, Dirk Fischer, et al.. (2015). Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects. BMC Neurology. 15(1). 182–182. 15 indexed citations

Rudnik‐Schöneborn, Sabine, Thomas Eggermann, Wolfram Kreß, et al.. (2015). Clinical utility gene card for: Proximal spinal muscular atrophy (SMA) – update 2015. European Journal of Human Genetics. 23(11). 1–3. 16 indexed citations

Schneiderat, Peter, Wolfram Kreß, Bernd Rautenstrauß, et al.. (2013). Facioscapulohumeral muscular dystrophy and Charcot-Marie-Tooth neuropathy 1A - evidence for “double trouble” overlapping syndromes. BMC Medical Genetics. 14(1). 92–92. 17 indexed citations

Vasli, Nasim, Marie Maurer, Belinda S. Cowling, et al.. (2013). Correction: Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy. PLoS Genetics. 9(6). 5 indexed citations

Kraya, Torsten, et al.. (2013). Myofibrilläre Myopathie bei ZASP-Mutation Ala147Thr: Zwei Fälle mit rein distalem Phänotyp der Beine. Der Nervenarzt. 84(2). 209–213. 1 indexed citations

Walter, Maggie C., Peter Reilich, Simone Thiele, et al.. (2013). Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial. Orphanet Journal of Rare Diseases. 8(1). 26–26. 78 indexed citations

Kasper, Elisabeth, Martin Wegrzyn, Ivo Marx, et al.. (2013). Minor cognitive disturbances in X-linked spinal and bulbar muscular atrophy, Kennedy's disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(1-2). 15–20. 16 indexed citations

10.

Kamsteeg, Erik‐Jan, Wolfram Kreß, Claudio Catalli, et al.. (2012). Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. European Journal of Human Genetics. 20(12). 1203–1208. 100 indexed citations

11.

Robb, S., Caroline A. Sewry, James J. Dowling, et al.. (2011). Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. Neuromuscular Disorders. 21(6). 379–386. 80 indexed citations

12.

Reilich, Peter, Benedikt Schoser, Nicolai Schramm, et al.. (2010). The p.G154S mutation of the alpha-B crystallin gene (CRYAB) causes late-onset distal myopathy. Neuromuscular Disorders. 20(4). 255–259. 67 indexed citations

13.

Jäger, Richard, et al.. (2008). Sustained Platelet-Derived Growth Factor Receptor α Signaling in Osteoblasts Results in Craniosynostosis by Overactivating the Phospholipase C-γ Pathway. Molecular and Cellular Biology. 29(3). 881–891. 38 indexed citations

14.

Hoffjan, Sabine, Charlotte Thiels, Matthias Vorgerd, et al.. (2006). Extreme phenotypic variability in a German family with X-linked myotubular myopathy associated with E404K mutation in MTM1. Neuromuscular Disorders. 16(11). 749–753. 14 indexed citations

15.

Huehne, Kathrin, Vladimír Beneš, Christian T. Thiel, et al.. (2002). Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1. Human Mutation. 21(1). 100–100. 15 indexed citations

16.

Liquori, Christina L., K. Ricker, Melinda L. Moseley, et al.. (2001). Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9. Science. 293(5531). 864–867. 918 indexed citations breakdown →

17.

Hu, Ling‐Jia, Jocelyn Laporte, Wolfram Kreß, & Niklas Dahl. (1996). PRENATAL DIAGNOSIS OF X-LINKED MYOTUBULAR MYOPATHY: STRATEGIES USING NEW AND TIGHTLY LINKED DNA MARKERS. Prenatal Diagnosis. 16(3). 231–237. 8 indexed citations

18.

Spiegel, Roland, Albert R. La Spada, Wolfram Kreß, Kenneth H. Fischbeck, & Werner Schmid. (1996). Somatic stability of the expanded CAG trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Human Mutation. 8(1). 32–37. 16 indexed citations

19.

Bittner, Reginald E., Sigrid Shorny, Wolfgang Sperl, et al.. (1995). Sarcolemmal expression of dystrophin C-terminus but reduced expression of 6q-dystrophin-related protein in two DMD patients with large deletions of the dystrophin gene. Neuromuscular Disorders. 5(2). 81–92. 3 indexed citations

20.

Schuster, Volker, Silvia Seidenspinner, T. Grimm, et al.. (1994). Molecular genetic haplotype segregation studies in three families with X-linked lymphoproliferative disease. European Journal of Pediatrics. 153(6). 432–437. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact